Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07039253 · ClinicalTrials.gov registry record · NA

Pilot Trial of Clinic-based Dating Violence Prevention Program for Adolescents and Caregivers

A NA study of Primary Care and Dating Violence, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT07039253: Recruiting NA study of Primary Care and Dating Violence, sponsored by University of Pittsburgh.

NCT07039253 is a NA study of Primary Care and Dating Violence that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 120 participants, below the 60,384-participant average among 5 other Primary Care trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07039253, a NA study of Primary Care and Dating Violence, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

ETHR V 2.0 pilot trial is a one-arm, multi-site pilot trial to assess the acceptability and feasibility of Engaging Together for Healthy Relationships, a caregiver-adolescent dating violence prevention program delivered within pediatric primary care.

Primary Outcome

Will assess through tracking data

Interventions

  • BEHAVIORAL Engaging Together for Health Relationships

Study Locations (1)

Pennsylvania

  • UPMC Children's Community Practice - Monongahela

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-08-15
Est. Completion 2026-12-01
Phase NA
University of Pittsburgh

1,238 total trials

What NCT07039253 shows while recruiting

NCT07039253 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 60,384-participant average among 5 other Primary Care trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Primary Care appearing as the primary indexed condition, and to 1 intervention - of which Engaging Together for Health Relationships is the first listed.

NCT07039253 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07039253 about?

NCT07039253 is a clinical study titled "Pilot Trial of Clinic-based Dating Violence Prevention Program for Adolescents and Caregivers". ETHR V 2.0 pilot trial is a one-arm, multi-site pilot trial to assess the acceptability and feasibility of Engaging Together for Healthy Relationships, a caregiver-adolescent dating violence prevention program delivered within pediatric primary care.

What is the current status of trial NCT07039253?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-08-15. Estimated completion is 2026-12-01.

What conditions does trial NCT07039253 study?

This clinical trial studies the following conditions: Primary Care, Dating Violence, Parent.

What interventions are being tested in trial NCT07039253?

The interventions under investigation include: Engaging Together for Health Relationships (BEHAVIORAL).

Who is sponsoring clinical trial NCT07039253?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07039253 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Primary Care

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07039253, the US trial registry maintained by the National Library of Medicine. NCT07039253 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.